Tıp Fakültesi by Institution Author "Özdemir, Mustafa"
Now showing items 1-1 of 1
-
Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Can we define better-responding endotypes?
Kocatürk, Emek; Bülbül Başkan, Emel; Küçük, Özlem Su; Özdemir, Mustafa; Örnek, Sinem; Can, Pelin Kuteyla; Haşal, Eda; Engin, Burhan; Atakan, Nilgün; Alpsoy, Erkan (Elsevier Science Inc, 2022)Background: Chronic Spontaneous Urticaria (CSU) is characterized by recurrent wheals and/or angioedema for longer than 6-weeks. Guidelines recommend Omalizumab (Oma) as first-line and Cyclosporine-A (Cs-A) as second-line ...